CD36 and atherosclerosis: Due to the profound reduction in CD11c+ (CD36+) monocytes and also reduced atherosclerosis in Ldlr−/− mice injected with P407, we used two experimental protocols (Figure 6A) to track CD11c+ (CD36+) monocyte trafficking into plaques.